Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Johanna Zech"'
Autor:
Jacob Golenser, Nicholas H. Hunt, Ida Birman, Charles L. Jaffe, Johanna Zech, Karsten Mäder, Daniel Gold
Publikováno v:
Global Challenges, Vol 7, Iss 12, Pp n/a-n/a (2023)
Abstract Employing new therapeutic indications for drugs that are already approved for human use has obvious advantages, including reduced costs and timelines, because some routine steps of drug development and regulation are not required. This work
Externí odkaz:
https://doaj.org/article/d17ea289b1af41a4894c3ba4239409ec
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 16, Iss , Pp 148-154 (2021)
Transdermal drug delivery avoids complications related to oral or parenteral delivery - the need for sterility, contamination, gastrointestinal side effects, patient unconsciousness or nausea and compliance. For malaria treatment, we demonstrate succ
Externí odkaz:
https://doaj.org/article/5ea7bd0df8ad4be384e3d7fb9c660d5c
Autor:
Johanna Zech, Michael Mader, Daniel Gündel, Hendrik Metz, Andreas Odparlik, Seema Agarwal, Karsten Mäder, Andreas Greiner
Publikováno v:
International Journal of Pharmaceutics: X, Vol 2, Iss , Pp 100055- (2020)
Highly porous 3D-scaffolds, made from cut, electrospun PLA fibers, are relatively new and promising systems for controlled drug-delivery applications. Because knowledge concerning fundamental processes of drug delivery from those scaffolds is limited
Externí odkaz:
https://doaj.org/article/1462edd4536143d994d69f5817198218
Autor:
Johanna Zech, Daniel Gold, Nadeen Salaymeh, Netanel Cohen Sasson, Ithai Rabinowitch, Jacob Golenser, Karsten Mäder
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 509 (2020)
Artemisone is an innovative artemisinin derivative with applications in the treatment of malaria, schistosomiasis and other diseases. However, its low aqueous solubility and tendency to degrade after solubilisation limits the translation of this drug
Externí odkaz:
https://doaj.org/article/5f02261ffc5646efa196de665ffa3b3d
Autor:
Christian Scheller, Johanna Zech, Sandra Leisz, Wolfgang Knolle, Frank Syrowatka, Karsten Mäder, Christian Strauss, Andreas Greiner, Benedikt Göttel
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 151:116-126
Nimodipine is a 1,4-Dihydropyridine type calcium antagonist routinely used to control blood pressure and reduce the risk of secondary ischemia after aneurismal subarachnoid hemorrhage. Additionally, Nimodipine has unique neuroprotective properties. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbaf388518921b74056d25fe6214b1d5
https://doi.org/10.1016/j.ejpb.2020.03.021
https://doi.org/10.1016/j.ejpb.2020.03.021
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d664f1ac7993be5b5b3b0c88a17d3801
https://doi.org/10.2139/ssrn.4252120
https://doi.org/10.2139/ssrn.4252120
Publikováno v:
Antimicrobial Agents and Chemotherapy
Artemisone (ART) has been successfully tested in vitro and in animal models against several diseases. However, its poor aqueous solubility and limited chemical stability are serious challenges.
Artemisone (ART) has been successfully tested in vi
Artemisone (ART) has been successfully tested in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5670403e24b4cc17fec3a05feae0ea38
https://pubmed.ncbi.nlm.nih.gov/33558284
https://pubmed.ncbi.nlm.nih.gov/33558284
Autor:
Karsten Mäder, Andreas Greiner, Andreas Odparlik, Seema Agarwal, Hendrik Metz, Michael Mader, Daniel Gündel, Johanna Zech
Publikováno v:
International Journal of Pharmaceutics: X, Vol 2, Iss, Pp 100055-(2020)
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X
Highly porous 3D-scaffolds, made from cut, electrospun PLA fibers, are relatively new and promising systems for controlled drug-delivery applications. Because knowledge concerning fundamental processes of drug delivery from those scaffolds is limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6c0052f9f579a64239868683a447da
https://pubmed.ncbi.nlm.nih.gov/32984812
https://pubmed.ncbi.nlm.nih.gov/32984812
Autor:
Hildegard Steger-Mauerhofer, Hanna Hacker, Sieglinde Osiebe, Traude Pietsch, Roberta Schaller-Steidl, Gertraud Seiser, Claudia Spring, Christine Stromberger, Madeleine Wolensky, Kirstin Breitenfellner, Christina Buder, Lizzi Kramberger, Evelyne Luef, Ursula Schneider, Johanna Zechner
Publikováno v:
Mitteilungen der Vereinigung Österreichischer Bibliothekarinnen und Bibliothekare, Vol 75, Iss 1 (2022)
Zum 30-jährigen Bestehen wurden alle seit Beginn an vernetzten Frauen* angefragt, ihre ‚persönliche frida-Geschichte’ zu teilen. Von den Aktivistinnen der Gründungsphase und den derzeit aktiven Frauen sind 15 Frauen* dieser Einladung nachgekom
Externí odkaz:
https://doaj.org/article/1532d6367e5f4e39af06e6eb6d602ec8